# Pelthos Therapeutics Inc.: Form 8-K, filed Jan 12, 2026

- Company: [Pelthos Therapeutics Inc.](/companies/pths.md) (CIK 1919246)
- Form: 8-K
- Filed: 2026-01-12
- Accepted by EDGAR: Jan 12, 2026, 16:31 ET
- Period: 2026-01-06
- Accession: 0001753926-26-000094
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1919246/000175392626000094/g085077_8k.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1919246/000175392626000094/

## Items reported

- Item 5.02: Departure or appointment of officers or directors
- Item 7.01: Regulation FD disclosure

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1919246/000175392626000094/g085077_8k.htm

Filed Jan 12, 2026.
Source: SEC EDGAR, the filing index for accession 0001753926-26-000094. Last ingested by Listed: Nov 13, 2026, 16:31 ET. No prices; not investment advice.
